Literature DB >> 12101268

A novel phenotype for an activated macrophage: the type 2 activated macrophage.

Charles F Anderson1, David M Mosser.   

Abstract

Activated macrophages were used as antigen presenting cells (APCs) to determine the extent to which these APCs could influence an adaptive immune response. We show that activated macrophages induced a strong polarized Th1-like T cell response that was predominated by IFN-gamma. However, when antigen was targeted to Fcgamma receptors on these macrophages, their phenotype changed, and they now induced a T cell response that was predominated by IL-4. The initial biasing by activated macrophages toward a Th1-like response was a result of activation of the innate immune response, as macrophages from MyD88(-/-) mice failed to produce Th1-inducing cytokines. The reversal of the Th1 biasing was a result of FcgammaR ligation, as macrophages lacking the FcR common gamma chain failed to reverse this biasing. To show that this biasing could occur in vivo, mice were injected with activated macrophages or activated macrophages whose FcgammaR had been ligated with an irrelevant immune complex. Mice injected with FcgammaR-ligated macrophages made more antibody than those receiving conventionally activated macrophages, and the antibody was predominantly of the IgG1 isotype. These studies demonstrate that FcgammaR ligation on activated macrophages can change the phenotype of these APCs to cells that preferentially drive a Th2-like response. We have termed these cells type 2 activated macrophages.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12101268

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  115 in total

1.  Identifying functional microRNAs in macrophages with polarized phenotypes.

Authors:  Joel W Graff; Anne M Dickson; Gwendolyn Clay; Anton P McCaffrey; Mary E Wilson
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

Review 2.  Regulatory macrophages: setting the threshold for therapy.

Authors:  Bryan D Fleming; David M Mosser
Journal:  Eur J Immunol       Date:  2011-09       Impact factor: 5.532

Review 3.  Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.

Authors:  Arsalan Alizadeh; Soheila Karimi-Abdolrezaee
Journal:  J Physiol       Date:  2016-03-29       Impact factor: 5.182

Review 4.  Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes.

Authors:  Robert D Stout; Jill Suttles
Journal:  Immunol Rev       Date:  2005-06       Impact factor: 12.988

5.  Biochemical and functional characterization of three activated macrophage populations.

Authors:  Justin P Edwards; Xia Zhang; Kenneth A Frauwirth; David M Mosser
Journal:  J Leukoc Biol       Date:  2006-08-11       Impact factor: 4.962

6.  Downregulation of mitogen-activated protein kinases by the Bordetella bronchiseptica Type III secretion system leads to attenuated nonclassical macrophage activation.

Authors:  Annette Reissinger; Jason A Skinner; Ming H Yuk
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 7.  Immune response to biologic scaffold materials.

Authors:  Stephen F Badylak; Thomas W Gilbert
Journal:  Semin Immunol       Date:  2008-02-20       Impact factor: 11.130

8.  Constitutive expression of pentraxin 3 (PTX3) protein by human amniotic membrane cells leads to formation of the heavy chain (HC)-hyaluronan (HA)-PTX3 complex.

Authors:  Suzhen Zhang; Ying-Ting Zhu; Szu-Yu Chen; Hua He; Scheffer C G Tseng
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

9.  TIPS pentacene loaded PEO-PDLLA core-shell nanoparticles have similar cellular uptake dynamics in M1 and M2 macrophages and in corresponding in vivo microenvironments.

Authors:  Dylan K McDaniel; Ami Jo; Veronica M Ringel-Scaia; Sheryl Coutermarsh-Ott; Daniel E Rothschild; Michael D Powell; Rui Zhang; Timothy E Long; Kenneth J Oestreich; Judy S Riffle; Richey M Davis; Irving C Allen
Journal:  Nanomedicine       Date:  2016-12-29       Impact factor: 5.307

10.  Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria.

Authors:  Frank A W Verreck; Tjitske de Boer; Dennis M L Langenberg; Marieke A Hoeve; Matthijs Kramer; Elena Vaisberg; Robert Kastelein; Arend Kolk; René de Waal-Malefyt; Tom H M Ottenhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.